Document Detail


Glucocorticoids in prevention of respiratory distress syndrome.
MedLine Citation:
PMID:  6997179     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Low doses of the synthetic steroid betamethasone can be effective in preventing neonatal RDS. Administration during the 48 hours immediately before delivery of infants between the 26th and 34th weeks of gestation is optimally effective. The article provides guidelines for this approach, describes its hazards, and discusses possible ways by which glucocorticoids prevent neonatal RDS.
Authors:
P L Ballard; R A Ballard
Related Documents :
9557239 - A review of infantile and pediatric acne.
21284459 - Analysis of the risk of shunt failure or infection related to cerebrospinal fluid cell ...
21401709 - Mother's body mass index as a predictor of infant's nutritional status in a the post-em...
21730909 - Congenital central hypoventilation syndrome: a case report.
10941649 - Management of flap striae.
21699999 - A neonatal mouse model of intermittent hypoxia associated with features of apnea in pre...
12777549 - Evaluation of cytomegalovirus infections transmitted via breast milk in preterm infants...
3558139 - The maturation of the central auditory conduction in preterm infants until three months...
11419769 - Differing influences on aboriginal and non-aboriginal neonatal phenotypes: a prospectiv...
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Hospital practice     Volume:  15     ISSN:  0018-5809     ISO Abbreviation:  Hosp Pract     Publication Date:  1980 Sep 
Date Detail:
Created Date:  1980-11-24     Completed Date:  1980-11-24     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0074404     Medline TA:  Hosp Pract     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  81-7     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amniotic Fluid / analysis
Betamethasone / adverse effects,  therapeutic use*
Birth Weight
Clinical Trials as Topic
Female
Fetal Organ Maturity / drug effects
Glucocorticoids / blood
Humans
Hydrocortisone / analysis
Infant, Newborn
Labor, Obstetric
Lung / drug effects,  embryology
Male
Pregnancy
Respiratory Distress Syndrome, Newborn / metabolism,  prevention & control*
Chemical
Reg. No./Substance:
0/Glucocorticoids; 378-44-9/Betamethasone; 50-23-7/Hydrocortisone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Insulin-like activity of bradykinin on amino acid balances across the human forearm.
Next Document:  Immune and autoimmune aspects of diabetes mellitus.